Fed. Circ. Told Arthrex Marks 'Significant Change' In Law
Customedia wants the full Federal Circuit to consider whether the company can raise a belated appointments clause challenge to a Patent Trial and Appeal Board decision in the wake of the court's...To view the full article, register now.
Already a subscriber? Click here to view full article